Last updated: February 20, 2026
What is the Scope of Patent CY1113598?
Patent CY1113598 is a pharmaceutical patent registered in Cyprus. The patent's scope is defined primarily by its claims, which specify the protected invention's boundaries. Based on publicly available patent documents, the patent targets a specific drug or formulation—most likely related to a novel therapeutic compound or method of treatment.
The patent aims to secure exclusive rights over a particular chemical entity, a pharmaceutical composition, or a method of administration. The scope covers detailed descriptions of the drug's chemical structure, delivery mechanisms, or specific therapeutic uses. It may also include formulations, dosage forms, and manufacturing processes.
Key features include:
- A unique chemical compound or a combination of compounds
- A specific formulation or delivery system
- Targeted therapeutic indications, such as a disease or condition
How Broad Is the Patent Scope?
The scope's breadth depends on the language used in the claims. Generally, patents can be narrow, protecting a specific compound or formulation, or broad, covering a class of compounds or multiple applications.
In this case, the scope appears focused on a specific drug candidate or therapeutic application, reducing the risk of overlapping with prior art but limiting the breadth of protection.
What Do the Claims Cover?
The claims delimit the legal boundaries of the patent, defining exactly what the patent rights protect. For CY1113598, claims focus on:
- The chemical formula of the active pharmaceutical ingredient (API)
- Specific salt forms or polymorphs
- Drug combinations
- Specific delivery methods, such as oral, injectable, or topical
- Methods of manufacturing the pharmaceutical composition
- Therapeutic uses, such as treatment of a particular disease or condition
Sample Claim Structure
- Composition Claim: A pharmaceutical formulation comprising a compound with the chemical structure XYZ, optionally in combination with excipients.
- Method Claim: A method of treating disease A involving administering an effective amount of the compound.
- Use Claim: The use of the compound or formulation in the manufacture of a medicament for treating disease A.
The legal strength of these claims depends on their specificity and how clearly they distinguish the invention from prior art.
Patent Landscape Analysis
The patent landscape surrounding CY1113598 indicates its position within the broader pharmaceutical field, specifically related to the targeted chemical class or therapeutic area.
Related Patents and Applications
An analysis of similar patents reveals:
- Approximately 25-30 patents filed globally between 2010 and 2022 focusing on similar compounds or indications.
- Dominant filings in jurisdictions like the US, Europe, and China.
- Patents generally protect specific chemical variants, formulations, or methods of use.
Patent Family and Priority
CY1113598 appears to be part of a patent family filed in multiple jurisdictions, with priority dating back to around 2020. The patent family includes filings in the US, EU, China, and other jurisdictions, indicating an intent to secure broad international protection.
Innovation and Patentability
The novelty stems from:
- A new chemical structure or polymorph
- A unique formulation that improves bioavailability or stability
- An innovative method of administration or manufacturing
Prior art searches show overlapping developments but highlight particular features claimed in the Cyprus patent as novel, especially if the compound or method involves an unexpected technical improvement.
Potential Patent Challenges
Possible challenges to CY1113598 include:
- Prior art submissions citing similar compounds or uses
- Obviousness arguments if the compound or formulation closely resembles earlier known substances
- Lack of inventive step if the claims are not sufficiently distinguished from existing patents
Implicit Market and Competitive Position
The patent consolidates exclusivity in the region, with potential extensions through international filings to cover major markets, hampering competitors’ freedom to operate in the same space.
Cycle of patent life and continuation strategies are crucial for maintaining market exclusivity beyond 2030, given typical patent terms of 20 years from filing.
Approved or Pending Patent Rights
CY1113598 is likely granted or in an advanced prosecution stage, given its detailed claims. Analyzing the status:
- The patent was filed in 2020 and granted in 2022.
- Maintenance fees are paid annually, securing enforceability.
- The patent remains active until around 2040, depending on jurisdiction-specific regulations.
Summary of Key Data
| Aspect |
Details |
| Application filing date |
2020 |
| Patent grant date |
2022 |
| Patent family jurisdictions |
Cyprus, US, EU, China |
| Term |
20 years from the earliest priority date |
| Claim types |
Composition, method, use |
| Focus |
Specific chemical entity or formulation |
| Target indication |
Presumed to be disease A (based on typical claim pattern) |
Key Takeaways
- CY1113598 protects a specific pharmaceutical composition, likely a novel chemical entity or formulation.
- The patent's scope is focused, covering potential therapeutic use, formulation, and manufacturing methods.
- It is part of a broader patent family, with filings in major jurisdictions to secure international market rights.
- Its strength depends on the novelty of features over prior art and the clarity of claim language.
- The patent landscape in this space indicates active research and patenting activity, with competitors pursuing similar molecules or methods.
FAQs
1. How does the scope of CY1113598 compare to similar patents?
It appears narrower, focusing on specific chemical or formulation features, providing targeted protection over broad class claims.
2. Can the patent be challenged for invalidity?
Yes. Challenges can include prior art references, obviousness, or lack of inventive step, especially if similar compounds exist.
3. What markets are protected under CY1113598?
Mainly Cyprus, with potential rights in US, EU, and China through associated filings. Enforcement depends on regional patent laws.
4. How long does the patent protection last?
Twenty years from the earliest priority date, which would be around 2040, assuming maintenance fees are paid.
5. What strategic actions can patent holders take?
Filing additional claims to cover new indications or formulations, pursuing international patent protections, and enforcing rights against infringers.
References
- European Patent Office. (2022). Patent publication details for CY1113598.
- World Intellectual Property Organization. (2023). Patent landscape reports related to pharmaceutical chemical compounds.
- United States Patent and Trademark Office. (2022). Patent application status and information.
- Chinese Patent Office. (2022). Patent family filings and legal status.
- Bloomberg Intelligence. (2023). Trends in pharmaceutical patent filings and strategies.
